Philadelphia, PENNSYLVANIA2 Active Studies

Hemophilia Clinical Trials in Philadelphia, PENNSYLVANIA

Find 2 actively recruiting hemophilia clinical trials in Philadelphia, PENNSYLVANIA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
393
Enrolling

Recruiting Hemophilia Studies in Philadelphia

About Hemophilia Clinical Trials in Philadelphia

Hemophilia is a rare genetic bleeding disorder in which blood does not clot properly due to deficiency of clotting factors. Hemophilia A (factor VIII) and hemophilia B (factor IX) are the most common types. Treatment includes factor replacement therapy and newer approaches like gene therapy.

There are currently 2 hemophilia clinical trials recruiting participants in Philadelphia, PENNSYLVANIA. These studies are seeking a combined 393 participants. Research is being sponsored by Pfizer, Regeneron Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.

Hemophilia Clinical Trials in Philadelphia — FAQ

Are there hemophilia clinical trials in Philadelphia?

Yes, there are 2 hemophilia clinical trials currently recruiting in Philadelphia, PENNSYLVANIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Philadelphia?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.

Are clinical trials in Philadelphia free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.

What hemophilia treatments are being tested?

The 2 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for hemophilia.

Data updated March 2, 2026 from ClinicalTrials.gov